Multi-asset investments views - October 2019: Market repricing
Not for Retail distribution: this document is intended exclusively for Professional, Institutional, Qualified or Wholesale Investors / Clients, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.

Our views
September witnessed interesting price action with a sharp rotation into pro-cyclical assets, indicating a potential repricing of global growth expectations. Global yields have risen, rates curves have bear-steepened, inflation break-evens widened, commodity indices rallied, whilst in equities value and cyclical stocks strongly outperformed growth and defensive stocks.
Most of these market moves were primarily driven by rates. We argued in our August Multi-Asset Investments views that market pricing of Fed fund rates was extremely aggressive which, coupled with extreme long duration positioning caused a strong reversal since the beginning of the month. Developments over the past few weeks catalysed this repricing, particularly following hints from Trump that trade negotiations are continuing with a possibility for trade detente. Positive data surprises - e.g. retail sales, industrial production and a solid rebound in non-manufacturing ISM in the US, more loosening signals in China in the form of RRR cuts and a lower probability of ‘No-deal Brexit’ in October also supported the rotation.
Market pricing is now consistent with our forecast of two more Fed cuts this year, but remain more dovish versus our forecast beyond 2019 as some recession risks continue to be priced into front-end rates. As a knock on, this re-pricing has channelled into positions within the equity market, causing a large rotation between equity factors from momentum and growth towards value and cyclicals. This movement can continue for a while until positioning is cleaner. This is why we maintain our slight cyclical tilt in our Euro equity exposure. We also remain constructive on Eurozone inflation break-evens as market pricing remains too pessimistic. This conviction is reinforced by the recent shock in oil prices following Saturday coordinated drone attacks on two oil facilities in Saudi Arabia. If sustained, this oil price move could support headline inflation.
Lastly, there is a lot of good news in S&P500 prices which are close to all-time highs. However, the underlying macro momentum remains weak. In this context, the 10% consensus 2020 earnings growth expectation looks optimistic. Therefore, we prefer to wait and see how trade negotiations proceed and maintain our slightly cautious stance on US equities for the moment.
Large reversals across and within asset classes in September

Source: Bloomberg, AXA IM Multi Asset Investments
Our key convictions:
• We keep a slight cyclical tilt in our Euro equity exposure as market pessimism on Eurozone growth is still extreme. We remain prudent on US equities as prices are close to all-time highs while the underlying macro momentum is weakening.
• We remain positive on US High Yield and Emerging Market debt as a more dovish Fed is supportive for carry positions
• We remain constructive on Eurozone inflation breakeven as market pricing remains too pessimistic
Our positioning:
• Underweight US equities
• Cyclical tilt in our Euro equity exposure
• Positive EM debt and US High Yield
• Positive Eurozone inflation breakeven
• Long equity call options delta hedged to protect the portfolios where possible
Not for Retail distribution: This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.
This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.
It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date. All information in this document is established on data made public by official providers of economic and market statistics. AXA Investment Managers disclaims any and all liability relating to a decision based on or for reliance on this document. All exhibits included in this document, unless stated otherwise, are as of the publication date of this document. Furthermore, due to the subjective nature of these opinions and analysis, these data, projections, forecasts, anticipations, hypothesis, etc. are not necessary used or followed by AXA IM’s portfolio management teams or its affiliates, who may act based on their own opinions. Any reproduction of this information, in whole or in part is, unless otherwise authorised by AXA IM, prohibited.
Neither MSCI nor any other party involved in or related to compiling, computing or creating the MSCI data makes any express or implied warranties or representations with respect to such data (or the results to be obtained by the use thereof), and all such parties hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability or fitness for a particular purpose with respect to any of such data. Without limiting any of the foregoing, in no event shall MSCI, any of its affiliates or any third party involved in or related to compiling, computing or creating the data have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages. No further distribution or dissemination of the MSCI data is permitted without MSCI’s express written consent.
Issued by AXA INVESTMENT MANAGERS PARIS, a company incorporated under the laws of France, having its registered office located at Tour Majunga, 6 place de la Pyramide, 92800 Puteaux, registered with the Nanterre Trade and Companies Register under number 353 534 506, and a Portfolio Management Company, holder of AMF approval no. GP 92-08, issued on 7 April 1992.
In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.